ALNY

#366
Alnylam Pharmaceuticals, Inc. - Common Stock
300.9 3 USD
-1.07%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
300.02
301.89
년간 변동
284.28
495.55
일일 변동
-1.07%
월간 변동
-2.13%
6달 변화
-33.11%
년간 변동율
+4.78%
이전 종가
304.2 0
Open
300.4 9
저가
300.0 2
High
301.8 9
양
453
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 40.18 B
  • Employee 2 500
  • Founded 2002
  • CEO Yvonne Greenstreet
  • Website www.alnylam.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000BFGNJ5
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
170.67
주가매출액비율
14.42

Alnylam Pharmaceuticals, Inc. - Common Stock

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

뉴스